JP2019535799A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019535799A5 JP2019535799A5 JP2019528746A JP2019528746A JP2019535799A5 JP 2019535799 A5 JP2019535799 A5 JP 2019535799A5 JP 2019528746 A JP2019528746 A JP 2019528746A JP 2019528746 A JP2019528746 A JP 2019528746A JP 2019535799 A5 JP2019535799 A5 JP 2019535799A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- treatment
- composition according
- disorders
- neurological
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 208000012902 Nervous system disease Diseases 0.000 claims 3
- 208000025966 Neurological disease Diseases 0.000 claims 3
- 208000020016 psychiatric disease Diseases 0.000 claims 3
- 102000048260 kappa Opioid Receptors Human genes 0.000 claims 1
- 230000000926 neurological effect Effects 0.000 claims 1
- 108020001588 κ-opioid receptors Proteins 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662426980P | 2016-11-28 | 2016-11-28 | |
| US62/426,980 | 2016-11-28 | ||
| US201762576435P | 2017-10-24 | 2017-10-24 | |
| US62/576,435 | 2017-10-24 | ||
| US201762585016P | 2017-11-13 | 2017-11-13 | |
| US62/585,016 | 2017-11-13 | ||
| PCT/IB2017/057418 WO2018096510A1 (en) | 2016-11-28 | 2017-11-27 | Heteroarylphenoxy benzamide kappa opioid ligands |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019535799A JP2019535799A (ja) | 2019-12-12 |
| JP2019535799A5 true JP2019535799A5 (cg-RX-API-DMAC7.html) | 2021-01-14 |
| JP7051853B2 JP7051853B2 (ja) | 2022-04-11 |
Family
ID=60782279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019528746A Active JP7051853B2 (ja) | 2016-11-28 | 2017-11-27 | ヘテロアリールフェノキシベンズアミドカッパオピオイドリガンド |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10316021B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3544972B8 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7051853B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN110234638B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017365123B2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3544972T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2947293T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI3544972T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20230518T1 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE061945T2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL266962B (cg-RX-API-DMAC7.html) |
| MX (1) | MX389806B (cg-RX-API-DMAC7.html) |
| PH (1) | PH12019501172A1 (cg-RX-API-DMAC7.html) |
| PL (1) | PL3544972T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT3544972T (cg-RX-API-DMAC7.html) |
| RS (1) | RS64258B1 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI720272B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018096510A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018154118A2 (en) * | 2017-02-24 | 2018-08-30 | Reinmueller Viktoria | Novel aromatic compounds |
| EP3585485A2 (en) | 2017-02-24 | 2020-01-01 | Xeniopro GmbH | Aromatic compounds which enhance notch signaling, for use in therapy |
| US11266627B1 (en) | 2021-05-04 | 2022-03-08 | Janssen Pharmaceuticals, Inc. | Compositions and methods for the treatment of depression |
| CN111233768B (zh) * | 2020-03-18 | 2021-08-03 | 徐州圣元化工有限公司 | 一种3-(二氟甲基)-1-甲基-1h-吡唑-4-羧酸乙酯的制备方法 |
| MX2021013934A (es) * | 2020-04-05 | 2021-12-15 | Pfizer | Compuestos y metodos para el tratamiento de covid-19. |
| US12161622B2 (en) | 2021-05-04 | 2024-12-10 | Janssen Pharmaceuticals, Inc. | Compositions and methods for the treatment of depression |
| CN119156202A (zh) | 2022-03-07 | 2024-12-17 | 杨森制药公司 | 包含阿替卡普兰的组合物 |
| JP2025508071A (ja) * | 2022-03-07 | 2025-03-21 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | 純粋な形態の結晶質アチカプラント |
| JP2025508051A (ja) | 2022-03-07 | 2025-03-21 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | 大うつ病性障害の治療に使用するためのアチカプラントの多形形態 |
| WO2024079733A1 (en) * | 2022-10-12 | 2024-04-18 | Adama Makhteshim Ltd. | Process for the preparation of aminopyridazine derivatives |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| GB9518953D0 (en) | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
| WO2000035298A1 (en) | 1996-11-27 | 2000-06-22 | Wm. Wrigley Jr. Company | Chewing gum containing medicament active agents |
| GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| JP2000159747A (ja) * | 1998-09-21 | 2000-06-13 | Takeda Chem Ind Ltd | 新規チオ―ル誘導体、その製造法および用途 |
| WO2000017162A1 (en) | 1998-09-21 | 2000-03-30 | Takeda Chemical Industries, Ltd. | Novel thiol derivatives, process for producing the same and utilization thereof |
| IT1303737B1 (it) | 1998-11-11 | 2001-02-23 | Smithkline Beecham Spa | Derivati fenilpiperidinici procedimento per la loro preparazione eloro uso come ligandi del recettore orl-1. |
| JP4646628B2 (ja) | 2002-09-19 | 2011-03-09 | イーライ リリー アンド カンパニー | オピオイド受容体アンタゴニストとしてのジアリールエーテル類 |
| US7365209B2 (en) | 2003-02-11 | 2008-04-29 | Pharmacopeia, Inc. | Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| CA2513791A1 (en) | 2003-03-07 | 2004-09-23 | Eli Lilly And Company | Opioid receptor antagonists |
| TW201018661A (en) | 2003-03-14 | 2010-05-16 | Ono Pharmaceutical Co | Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient |
| AU2005268030B2 (en) | 2004-08-06 | 2009-02-19 | Otsuka Pharmaceutical Co., Ltd. | Aromatic compounds |
| KR100922093B1 (ko) | 2005-02-18 | 2009-10-16 | 닛뽕소다 가부시키가이샤 | 유기 무기 복합체 |
| JPWO2007105637A1 (ja) | 2006-03-10 | 2009-07-30 | 小野薬品工業株式会社 | 含窒素複素環誘導体およびそれらを有効成分とする薬剤 |
| CA2646899C (en) | 2006-04-04 | 2014-05-06 | Holger Lars Hermann | Use of compositions containing kappa-opioid receptor antagonists for the treatment of dissociative disorders |
| SI2252581T1 (sl) | 2008-01-22 | 2012-09-28 | Lilly Co Eli | Antagonist kappa selektivnega opioidnega receptorja |
| US8242145B2 (en) | 2008-02-14 | 2012-08-14 | Panmira Pharmaceuticals, Llc | Cyclic diaryl ether compounds as antagonists of prostaglandin D2 receptors |
| CR11559A (es) | 2008-03-25 | 2010-10-20 | Lilly Co Eli | Antagonista del receptor opioide selectivo kappa |
| US8048895B2 (en) | 2008-04-18 | 2011-11-01 | Research Triangle Institute | Kappa opioid receptor ligands |
| CA2986640C (en) | 2008-06-27 | 2019-03-26 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
| CA2746943A1 (en) | 2008-12-18 | 2010-07-15 | Boehringer Ingelheim International Gmbh | Serotonin 5-ht2b receptor inhibitors |
| HN2010001319A (es) | 2009-01-26 | 2013-01-15 | Lilly Co Eli | Antagonista del receptor opioide selectivo kappa |
| WO2013059648A1 (en) | 2011-10-21 | 2013-04-25 | Neurotherapeutics Pharma, Inc. | 2,3,5 trisubstituted aryl and heteroaryl amino derivatives, compositions, and methods of use |
| JP2015531382A (ja) | 2012-10-02 | 2015-11-02 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | ピロリジン |
| WO2015109080A1 (en) | 2014-01-15 | 2015-07-23 | Research Triangle Institute | Kappa-opioid receptor selective opioid receptor antagonists |
| US10118896B2 (en) | 2014-11-26 | 2018-11-06 | University Of Kansas | Antagonists of the kappa opioid receptor |
-
2017
- 2017-11-22 US US15/820,679 patent/US10316021B2/en active Active
- 2017-11-27 ES ES17818281T patent/ES2947293T3/es active Active
- 2017-11-27 JP JP2019528746A patent/JP7051853B2/ja active Active
- 2017-11-27 FI FIEP17818281.2T patent/FI3544972T3/fi active
- 2017-11-27 HU HUE17818281A patent/HUE061945T2/hu unknown
- 2017-11-27 HR HRP20230518TT patent/HRP20230518T1/hr unknown
- 2017-11-27 RS RS20230453A patent/RS64258B1/sr unknown
- 2017-11-27 WO PCT/IB2017/057418 patent/WO2018096510A1/en not_active Ceased
- 2017-11-27 PL PL17818281.2T patent/PL3544972T3/pl unknown
- 2017-11-27 MX MX2019006220A patent/MX389806B/es unknown
- 2017-11-27 AU AU2017365123A patent/AU2017365123B2/en active Active
- 2017-11-27 PT PT178182812T patent/PT3544972T/pt unknown
- 2017-11-27 TW TW106141134A patent/TWI720272B/zh active
- 2017-11-27 DK DK17818281.2T patent/DK3544972T3/da active
- 2017-11-27 CN CN201780084763.0A patent/CN110234638B/zh active Active
- 2017-11-27 EP EP17818281.2A patent/EP3544972B8/en active Active
-
2019
- 2019-05-28 PH PH12019501172A patent/PH12019501172A1/en unknown
- 2019-05-28 IL IL266962A patent/IL266962B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019535799A5 (cg-RX-API-DMAC7.html) | ||
| IL269599A (en) | 11, 13- modified schistosoxins for pain treatment | |
| MA49402A (fr) | Polynucléotides aadc pour le traitement de la maladie de parkinson | |
| JP2016515522A5 (cg-RX-API-DMAC7.html) | ||
| HRP20210518T1 (hr) | Derivati 2,4-tiazolidindiona, namijenjeni liječenju poremećaja središnjeg živčanog sustava | |
| WO2016100162A3 (en) | 5,5-bicyclic oxazole orexin receptor antagonists | |
| WO2016100157A3 (en) | 6,5-bicyclic octahydropyrrolopyridine orexin receptor antagonists | |
| IL269310A (en) | Use of designer receptors exclusively activated by designer drugs in the treatment of seizure disorders | |
| SMT202200228T1 (it) | Trattamento per la malattia di parkinson | |
| WO2017070689A3 (en) | Solabegron zwitterion and uses thereof | |
| LT3413870T (lt) | Igmesinas, skirtas panaudoti alzheimerio ligos gydymui | |
| EP3589305C0 (en) | SPECIFIC INCREASE IN DOPAMINE SYNTHESIS BY TARGETING THE GUANYLATE CYCLASE 2C RECEPTOR IN THE TREATMENT OF PARKINSON'S DISEASE | |
| EA201791398A1 (ru) | Производные фумагиллола | |
| MA40065A (fr) | N, n-bis-2-mercaptoéthyle isophtalamide pour le traitement de la maladie de parkinson | |
| ZA201807944B (en) | Treatment for parkinson's disease | |
| IT201700006355A1 (it) | Composizione per il trattamento dei disturbi gastrointestinali | |
| SG10201912846PA (en) | Therapeutic agent for non-motor symptoms associated with parkinson's disease | |
| ZA201704287B (en) | 3.alpha.-ethynyl, 3.beta.-hydroxy-5.alpha.-pregnan-20-oxime for use in the treatment of cns disorders | |
| HK1245077A1 (en) | Compositions and methods of treating a neurodegenerative disease | |
| ITUB20153076A1 (it) | Composti farmaceuticamente attivi per l?impiego nel trattamento terapeutico di disturbi del movimento. | |
| HK1245275A1 (en) | Fumagillol derivatives |